Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $0.30 in the prior trading day, Intensity Therapeutics Inc (NASDAQ: INTS) closed at $985.69K, up 969582%. In other words, the price has increased by $969582 from its previous closing price. On the day, 0.97 million shares were traded. INTS stock price reached its highest trading level at $0.3117 during the session, while it also had its lowest trading level at $0.277.
Ratios:
Our goal is to gain a better understanding of INTS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.63. In the meantime, Its Debt-to-Equity ratio is 0.39 whereas as Long-Term Debt/Eq ratio is at 0.30.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INTS now has a Market Capitalization of 7222637 and an Enterprise Value of 4298302.
Stock Price History:
The Beta on a monthly basis for INTS is 4.37, which has changed by -0.9454724 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, INTS has reached a high of $5.10, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is -62.89%, while the 200-Day Moving Average is calculated to be -87.67%.
Shares Statistics:
The stock has traded on average 985.69K shares per day over the past 3-months and 3396700 shares per day over the last 10 days, according to various share statistics. A total of 15.26M shares are outstanding, with a floating share count of 10.02M. Insiders hold about 45.56% of the company’s shares, while institutions hold 14.07% stake in the company. Shares short for INTS as of 1748563200 were 461635 with a Short Ratio of 0.47, compared to 1745971200 on 174784. Therefore, it implies a Short% of Shares Outstanding of 461635 and a Short% of Float of 3.32.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Intensity Therapeutics Inc (INTS) is currently being evaluated by 1 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.7 and -$0.7 for the fiscal current year, implying an average EPS of -$0.7. EPS for the following year is -$0.47, with 2.0 analysts recommending between -$0.45 and -$0.5.
